ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · Real-Time Price · USD
5.33
-0.17 (-3.09%)
Dec 15, 2025, 1:00 PM EST - Market open
ENDRA Life Sciences Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for ENDRA Life Sciences stock has a target of 30, which predicts a 462.85% increase from the current stock price of 5.33.
Price Target: $30 (+462.85%)
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for ENDRA Life Sciences is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $38 → $30 | Strong Buy | Maintains | $38 → $30 | +462.85% | Dec 8, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $46 → $38 | Strong Buy | Maintains | $46 → $38 | +612.95% | Sep 22, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $50 → $46 | Strong Buy | Maintains | $50 → $46 | +763.04% | May 30, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $75 → $50 | Strong Buy | Maintains | $75 → $50 | +838.09% | Apr 21, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $17,500 → $14,000 | Strong Buy | Maintains | $17,500 → $14,000 | +262,564.17% | Jun 7, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
306.00K
EPS This Year
-7.63
from -56.94
EPS Next Year
-9.07
from -7.63
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | n/a | 315,000 |
| Avg | n/a | 306,000 |
| Low | n/a | 294,000 |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -7.85 | -9.33 |
| Avg | -7.63 | -9.07 |
| Low | -7.33 | -8.71 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.